Given their role in various diseases, miRNAs are potential therapeutic targets. Strategies to modulate miRNA activity include the use of miRNA mimics to restore the function of downregulated miRNAs, or miRNA inhibitors (antagomirs) to silence overexpressed miRNAs. These approaches are being explored in clinical trials for various pediatric conditions.
